Ojas, Hilda G.
HRN: 10-82-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2022
CEFTRIAXONE 1G (VIAL)
11/06/2022
11/12/2022
IVT
2gms
Od
Cap Mr, T/c Copd In Ae
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes